Cancer-associated fibroblasts: key determinants of tumor immunity and immunotherapy
Open Access
- 11 May 2020
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 64, 80-87
- https://doi.org/10.1016/j.coi.2020.03.004
Abstract
No abstract availableThis publication has 93 references indexed in Scilit:
- CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancerProceedings of the National Academy of Sciences, 2013
- The Pancreas Cancer MicroenvironmentClinical Cancer Research, 2012
- Human Colonic Myofibroblasts Promote Expansion of CD4+ CD25high Foxp3+ Regulatory T CellsGastroenterology, 2011
- Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancerDisease Models & Mechanisms, 2011
- Autocrine TGF-β and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblastsProceedings of the National Academy of Sciences, 2010
- Chemokines and chemokine receptors: new insights into cancer-related inflammationTrends in Molecular Medicine, 2010
- Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicityProceedings of the National Academy of Sciences, 2009
- Myeloid-derived suppressor cells as regulators of the immune systemNature Reviews Immunology, 2009
- PD-1 Ligand Expression by Human Colonic Myofibroblasts/Fibroblasts Regulates CD4+ T-Cell ActivityGastroenterology, 2008
- Adoptive cell transfer: a clinical path to effective cancer immunotherapyNature Reviews Cancer, 2008